Integrated Biopharma Inc (INBP): Net Income
-$2.84M
Year ended 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$2.84M | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | $808.0K | +621.4% | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | $112.0K | n/m | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | -$34.0K | n/m | 2024-09-20, From 2022-07-01 |
| 2022-06-30 | $3.84M | -52.1% | 2023-09-15, From 2021-07-01 |
| 2021-06-30 | $8.01M | +95.1% | 2022-09-13, From 2020-07-01 |
| 2020-06-30 | $4.11M | +143.4% | 2021-09-02, From 2019-07-01 |
| 2019-06-30 | $1.69M | +148.6% | 2020-09-23, From 2018-07-01 |
| 2018-06-30 | $679.0K | -71.1% | 2019-08-29, From 2017-07-01 |
| 2017-06-30 | $2.35M | +144.9% | 2018-09-12, From 2016-07-01 |
| 2016-06-30 | $958.0K | +30.3% | 2017-09-01, From 2015-07-01 |
| 2015-06-30 | $735.0K | +461.1% | 2016-09-02, From 2014-07-01 |
| 2014-06-30 | $131.0K | +40.9% | 2015-09-04, From 2013-07-01 |
| 2013-06-30 | $93.0K | n/m | 2014-09-08, From 2012-07-01 |
| 2012-06-30 | -$2.71M | n/m | 2013-09-30, From 2011-07-01 |
| 2011-06-30 | -$2.28M | n/a | 2012-10-15, From 2010-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Integrated Biopharma Inc (INBP) | 2026-06-30 | -$2.84M | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$35.04M | n/m |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | -$2.84M | n/m |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$83.78M | n/m |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | -$204.38M | n/m |
| Septerna, Inc. (SEPN) | 2025-12-31 | -$48.88M | n/m |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | -$130.15M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$10.54M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$170.37M | n/m |
Compare INBP, XLO, CPIX, AQST side by side · Screen every company in Pharmaceutical Preparations ↗